Diabetes exacerbates the progression of atherosclerosis and is associated with increased
risk of developing acute coronary syndrome (ACS). Approximatively 25–30% of patients …

The main causes of death in patients with chronic kidney disease (CKD) are of
cardiovascular nature. The interaction between traditional cardiovascular risk factors (CVRF) …

目的: 探究同型半胱氨酸(Hcy) 联合C 反应蛋白/白蛋白比值(CAR) 对急性ST 段抬高型心肌梗死(
STEMI) 合并代谢综合征(MS) 患者急诊行经皮冠状动脉介入(PCI) 术后无复流(NRP) …

The values of hematological and coagulation biomarkers were evaluated as predictors of in
hospital mortality and complications, in patients with acute coronary syndromes (ACS). This …

Although major advances have occurred lately in medical therapy, ischemic heart failure
remains an important cause of death and disability. Viable myocardium represents a cause …

Background Acute total occlusion (ATO) is diagnosed in a substantial proportion of patients
with non-ST-elevation myocardial infarction (NSTEMI). We compared procedural outcomes …

Currently, the gold standard treatment for ST-elevation myocardial infarction (STEMI) is
primary percutaneous coronary intervention (pPCI), but even after successful pPCI, a …

Immune-inflammatory biomarkers have been shown to be correlated with impaired coronary
flow (ICF) in ST-segment elevation myocardial infarction. In this study, we assessed the …

Background No‐/slow‐reflow phenomenon (NRP) is a severe complication in patients with
ST‐segment elevation myocardial infarction (STEMI) undergoing primary percutaneous …

This study aimed to evaluate the relationship between no-reflow phenomenon and systemic
inflammation index (SII) and to compare the predictive capacity of SII together with the …